The U.S. health regulator has approved expanding the use of Revance Therapeutics' Daxxify to treat a painful neck muscle condition, intensifying the anti-wrinkle injection's rivalry with AbbVie's Botox.
The approval by the Food and Drug Administration helps Revance enter the $2.5 billion U.S. market for therapeutic neuromodulator, a method that directly acts on nerves, the company said on Monday.
Revance will move into a preview phase with some doctors and key opinion leaders initially after the approval, company executives told Reuters before the decision. Revance said it would share more information on the pricing when the product is launched commercially.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Britney Spears Says She Had 'Reverse Effect' to Getting BotoxBritney Spears revealed why she will ‘never again’ undergo Botox procedures in a candid message
Consulte Mais informação »
RHOC's Heather Dubrow Slams ‘Ozempic-Shaming,’ Compares Drug to BotoxHeather Dubrow exclusively explained to Us Weekly why she is not a fan of celebrities being called out for using Ozempic or other weight-management drugs
Consulte Mais informação »
'RHOC' star Heather Dubrow blasts 'Ozempic shaming,' compares stigma on weight loss drug to Botox'The Real Housewives of Orange County' star Heather Dubrow slammed critics for 'Ozempic-shaming' celebrities, comparing the stigma of taking Ozempic to how getting Botox once was.
Consulte Mais informação »
Listeria outbreak may be linked to recalled ice cream cups, FDA saysTwo people have recently been hospitalized from the bacteria, according to officials.
Consulte Mais informação »